This database includes MPT products that are currently in active development. The database outlines detailed product information and can be searched to display products by desired criteria as selected from the drop-down boxes or by entering a keyword in the search box. Click on the product name to access detailed information on each product. Please note there are other MPT candidates not listed that may move forward pending funding. Click here to learn more about the inclusion criteria and information update methodology.
Click on the table for MPT products in the development pipeline by indication combination.
Know of an MPT product not included in this database or have updated information for listed products? Let us know here!
MB66 Film
MPT in Development
Development Stage:
Clinical – Phase 1 Trial (C1)
Hormonal/Non-Hormonal:
Non-Contraceptive
Delivery Route & Method:
Topical -
Film - Vaginal
Mechanism of Action:
virus neutralization, mucus trapping
Developer:
Mapp Biopharmaceutical, Inc.
Funding:
DAIDS
Nat. Institute Allergy & Infect. Diseases (NIAID)
Active Ingredient:
Monoclonal Antibodies
Product Indications:
HIV
HSV-2
Description: Plant produced anti-HIV and anti-HSV antibodies. Phase 1 clinical trial ends Q3 2018. The next generation of MB66 will include an anti-sperm human contraceptive antibody (HCA).
